Tff Pharmaceuticals Valuation
| TFFP Stock | USD 0.30 0.02 6.25% |
Tff Pharmaceuticals seems to be undervalued based on Macroaxis valuation methodology. Our model measures the value of Tff Pharmaceuticals from inspecting the company fundamentals such as Shares Owned By Insiders of 3.31 %, current valuation of (1.2 M), and Return On Equity of -2.14 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Tff Pharmaceuticals' valuation include:
Price Book 0.4305 | Enterprise Value -1.2 M | Enterprise Value Ebitda (0.50) | Price Sales 1.1231 | Enterprise Value Revenue 7.88 |
Undervalued
Today
Please note that Tff Pharmaceuticals' price fluctuation is abnormally volatile at this time. Calculation of the real value of Tff Pharmaceuticals is based on 3 months time horizon. Increasing Tff Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Tff Pharmaceuticals' intrinsic value may or may not be the same as its current market price of 0.30, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.3 | Real 2.03 | Target 7.25 | Hype 0.19 | Naive 0.25 |
The intrinsic value of Tff Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Tff Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Tff Pharmaceuticals helps investors to forecast how Tff stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tff Pharmaceuticals more accurately as focusing exclusively on Tff Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Tff Pharmaceuticals' intrinsic value based on its ongoing forecasts of Tff Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Tff Pharmaceuticals' closest peers.
Tff Pharmaceuticals Cash |
|
Tff Valuation Trend
Tff Pharmaceuticals' real value is important for investors to make better decisions and a more accurate overall view of Tff Pharmaceuticals' financial worth over time. Using both Tff Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Tff Pharmaceuticals Total Value Analysis
Tff Pharmaceuticals is at this time forecasted to have valuation of (1.2 M) with market capitalization of 1.35 M, debt of 115.25 K, and cash on hands of 13.15 M. The negative valuation of Tff Pharmaceuticals may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Tff Pharmaceuticals fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(1.2 M) | 1.35 M | 115.25 K | 13.15 M |
Tff Pharmaceuticals Investor Information
About 24.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.43. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tff Pharmaceuticals recorded a loss per share of 5.5. The entity had not issued any dividends in recent years. The firm had 1:25 split on the 19th of December 2023. Based on the key indicators related to Tff Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Tff Pharmaceuticals is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Tff Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Tff Pharmaceuticals has an asset utilization ratio of 6.1 percent. This connotes that the Company is making $0.061 for each dollar of assets. An increasing asset utilization means that Tff Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Tff Pharmaceuticals Ownership Allocation
Tff Pharmaceuticals has 3.31 % of its outstanding shares held by insiders and 24.37 % owned by institutional holders.Tff Pharmaceuticals Profitability Analysis
The company reported the previous year's revenue of 733.87 K. Net Loss for the year was (21.24 M) with loss before overhead, payroll, taxes, and interest of (21.21 M).About Tff Pharmaceuticals Valuation
The stock valuation mechanism determines Tff Pharmaceuticals' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Tff Pharmaceuticals based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tff Pharmaceuticals. We calculate exposure to Tff Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Tff Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 231.4 K | 243 K | |
| Pretax Profit Margin | (26.05) | (27.35) | |
| Operating Profit Margin | (26.85) | (28.19) | |
| Net Loss | (26.05) | (27.35) | |
| Gross Profit Margin | 0.28 | 0.26 |
Tff Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Tff Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.8 M |
Tff Pharmaceuticals Current Valuation Indicators
Tff Pharmaceuticals' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Tff Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Tff Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Tff Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Tff Pharmaceuticals' worth.Additional Tools for Tff Stock Analysis
When running Tff Pharmaceuticals' price analysis, check to measure Tff Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tff Pharmaceuticals is operating at the current time. Most of Tff Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tff Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tff Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tff Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.